Logo image of KIN.BR

KINEPOLIS (KIN.BR) Stock Fundamental Analysis

Europe - Euronext Brussels - EBR:KIN - BE0974274061 - Common Stock

28.75 EUR
+0.45 (+1.59%)
Last: 1/9/2026, 7:00:00 PM
Fundamental Rating

4

KIN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 45 industry peers in the Entertainment industry. There are concerns on the financial health of KIN while its profitability can be described as average. A decent growth rate in combination with a cheap valuation! Better keep an eye on KIN.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

KIN had positive earnings in the past year.
In the past year KIN had a positive cash flow from operations.
In multiple years KIN reported negative net income over the last 5 years.
Of the past 5 years KIN 4 years had a positive operating cash flow.
KIN.BR Yearly Net Income VS EBIT VS OCF VS FCFKIN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.54%, KIN is in the better half of the industry, outperforming 75.56% of the companies in the same industry.
KIN's Return On Equity of 23.61% is amongst the best of the industry. KIN outperforms 82.22% of its industry peers.
KIN's Return On Invested Capital of 8.28% is fine compared to the rest of the industry. KIN outperforms 80.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for KIN is below the industry average of 9.60%.
The last Return On Invested Capital (8.28%) for KIN is above the 3 year average (6.76%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.54%
ROE 23.61%
ROIC 8.28%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
KIN.BR Yearly ROA, ROE, ROICKIN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

The Profit Margin of KIN (7.98%) is better than 75.56% of its industry peers.
KIN's Profit Margin has declined in the last couple of years.
The Operating Margin of KIN (15.19%) is better than 91.11% of its industry peers.
In the last couple of years the Operating Margin of KIN has declined.
With a Gross Margin value of 24.54%, KIN is not doing good in the industry: 84.44% of the companies in the same industry are doing better.
KIN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 15.19%
PM (TTM) 7.98%
GM 24.54%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
KIN.BR Yearly Profit, Operating, Gross MarginsKIN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

2

2. Health

2.1 Basic Checks

KIN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for KIN remains at a similar level compared to 1 year ago.
The number of shares outstanding for KIN has been increased compared to 5 years ago.
Compared to 1 year ago, KIN has an improved debt to assets ratio.
KIN.BR Yearly Shares OutstandingKIN.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
KIN.BR Yearly Total Debt VS Total AssetsKIN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

KIN has an Altman-Z score of 1.51. This is a bad value and indicates that KIN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.51, KIN is in the better half of the industry, outperforming 64.44% of the companies in the same industry.
KIN has a debt to FCF ratio of 5.38. This is a neutral value as KIN would need 5.38 years to pay back of all of its debts.
The Debt to FCF ratio of KIN (5.38) is comparable to the rest of the industry.
A Debt/Equity ratio of 2.87 is on the high side and indicates that KIN has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.87, KIN is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF 5.38
Altman-Z 1.51
ROIC/WACC1.47
WACC5.65%
KIN.BR Yearly LT Debt VS Equity VS FCFKIN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

KIN has a Current Ratio of 0.47. This is a bad value and indicates that KIN is not financially healthy enough and could expect problems in meeting its short term obligations.
KIN has a Current ratio of 0.47. This is amonst the worse of the industry: KIN underperforms 86.67% of its industry peers.
A Quick Ratio of 0.44 indicates that KIN may have some problems paying its short term obligations.
KIN has a worse Quick ratio (0.44) than 86.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.44
KIN.BR Yearly Current Assets VS Current LiabilitesKIN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 34.32% over the past year.
KIN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.80% yearly.
The Revenue has been growing slightly by 5.38% in the past year.
KIN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.95% yearly.
EPS 1Y (TTM)34.32%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%5581.82%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%6.22%

3.2 Future

The Earnings Per Share is expected to grow by 14.94% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.98% on average over the next years.
EPS Next Y22.89%
EPS Next 2Y26.59%
EPS Next 3Y21.24%
EPS Next 5Y14.94%
Revenue Next Year3.49%
Revenue Next 2Y9.56%
Revenue Next 3Y7.85%
Revenue Next 5Y4.98%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
KIN.BR Yearly Revenue VS EstimatesKIN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
KIN.BR Yearly EPS VS EstimatesKIN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.81 indicates a correct valuation of KIN.
Compared to the rest of the industry, the Price/Earnings ratio of KIN indicates a rather cheap valuation: KIN is cheaper than 91.11% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.19, KIN is valued a bit cheaper.
The Price/Forward Earnings ratio is 10.70, which indicates a very decent valuation of KIN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of KIN indicates a rather cheap valuation: KIN is cheaper than 86.67% of the companies listed in the same industry.
KIN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.88.
Industry RankSector Rank
PE 16.81
Fwd PE 10.7
KIN.BR Price Earnings VS Forward Price EarningsKIN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

KIN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. KIN is cheaper than 71.11% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of KIN indicates a rather cheap valuation: KIN is cheaper than 84.44% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.02
EV/EBITDA 8.24
KIN.BR Per share dataKIN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
KIN's earnings are expected to grow with 21.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.73
PEG (5Y)N/A
EPS Next 2Y26.59%
EPS Next 3Y21.24%

3

5. Dividend

5.1 Amount

KIN has a Yearly Dividend Yield of 1.36%.
Compared to an average industry Dividend Yield of 0.85, KIN pays a bit more dividend than its industry peers.
KIN's Dividend Yield is slightly below the S&P500 average, which is at 1.90.
Industry RankSector Rank
Dividend Yield 1.36%

5.2 History

The dividend of KIN decreases each year by -3.32%.
Dividend Growth(5Y)-3.32%
Div Incr Years1
Div Non Decr Years2
KIN.BR Yearly Dividends per shareKIN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

31.09% of the earnings are spent on dividend by KIN. This is a low number and sustainable payout ratio.
DP31.09%
EPS Next 2Y26.59%
EPS Next 3Y21.24%
KIN.BR Yearly Income VS Free CF VS DividendKIN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
KIN.BR Dividend Payout.KIN.BR Dividend Payout, showing the Payout Ratio.KIN.BR Dividend Payout.PayoutRetained Earnings

KINEPOLIS

EBR:KIN (1/9/2026, 7:00:00 PM)

28.75

+0.45 (+1.59%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-21 2025-08-21
Earnings (Next)02-20 2026-02-20/amc
Inst Owners17.67%
Inst Owner ChangeN/A
Ins Owners1.8%
Ins Owner ChangeN/A
Market Cap786.89M
Revenue(TTM)593.29M
Net Income(TTM)47.32M
Analysts86
Price Target49.3 (71.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.36%
Yearly Dividend0.54
Dividend Growth(5Y)-3.32%
DP31.09%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.34%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-6.85%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.14%
Valuation
Industry RankSector Rank
PE 16.81
Fwd PE 10.7
P/S 1.33
P/FCF 6.02
P/OCF 4.54
P/B 3.93
P/tB 35.11
EV/EBITDA 8.24
EPS(TTM)1.71
EY5.95%
EPS(NY)2.69
Fwd EY9.34%
FCF(TTM)4.77
FCFY16.6%
OCF(TTM)6.34
OCFY22.05%
SpS21.68
BVpS7.32
TBVpS0.82
PEG (NY)0.73
PEG (5Y)N/A
Graham Number16.79
Profitability
Industry RankSector Rank
ROA 4.54%
ROE 23.61%
ROCE 11.27%
ROIC 8.28%
ROICexc 8.93%
ROICexgc 11.76%
OM 15.19%
PM (TTM) 7.98%
GM 24.54%
FCFM 22.02%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
ROICexc(3y)7.02%
ROICexc(5y)N/A
ROICexgc(3y)8.91%
ROICexgc(5y)N/A
ROCE(3y)9.19%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1%
ROICexc growth 3YN/A
ROICexc growth 5Y-1.69%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
F-Score8
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF 5.38
Debt/EBITDA 3.35
Cap/Depr 52.23%
Cap/Sales 7.23%
Interest Coverage 4.1
Cash Conversion 100.75%
Profit Quality 276.05%
Current Ratio 0.47
Quick Ratio 0.44
Altman-Z 1.51
F-Score8
WACC5.65%
ROIC/WACC1.47
Cap/Depr(3y)43.12%
Cap/Depr(5y)41.32%
Cap/Sales(3y)6.29%
Cap/Sales(5y)10.19%
Profit Quality(3y)301.12%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.32%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%5581.82%
EPS Next Y22.89%
EPS Next 2Y26.59%
EPS Next 3Y21.24%
EPS Next 5Y14.94%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%6.22%
Revenue Next Year3.49%
Revenue Next 2Y9.56%
Revenue Next 3Y7.85%
Revenue Next 5Y4.98%
EBIT growth 1Y16.5%
EBIT growth 3YN/A
EBIT growth 5Y-3.89%
EBIT Next Year104.02%
EBIT Next 3Y35.57%
EBIT Next 5Y22.36%
FCF growth 1Y30.27%
FCF growth 3Y19%
FCF growth 5Y6.53%
OCF growth 1Y26.43%
OCF growth 3Y22.57%
OCF growth 5Y1.63%

KINEPOLIS / KIN.BR FAQ

Can you provide the ChartMill fundamental rating for KINEPOLIS?

ChartMill assigns a fundamental rating of 4 / 10 to KIN.BR.


Can you provide the valuation status for KINEPOLIS?

ChartMill assigns a valuation rating of 8 / 10 to KINEPOLIS (KIN.BR). This can be considered as Undervalued.


What is the profitability of KIN stock?

KINEPOLIS (KIN.BR) has a profitability rating of 5 / 10.


What are the PE and PB ratios of KINEPOLIS (KIN.BR) stock?

The Price/Earnings (PE) ratio for KINEPOLIS (KIN.BR) is 16.81 and the Price/Book (PB) ratio is 3.93.


Is the dividend of KINEPOLIS sustainable?

The dividend rating of KINEPOLIS (KIN.BR) is 3 / 10 and the dividend payout ratio is 31.09%.